SCHEMBL13521968

SCHEMBL13521968

CC(C)(C)C(=O)Nc1ccc(Oc2cc(Cl)cc(CC(=O)O)c2)c(CS)c1

nearest known ligand 0.51

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.51
PTGDR2 Q9Y5Y4 10/20 0.42
PTGDR Q13258 1/20 0.41
P2RX4 Q99571 5/20 0.38
CYP2C8 P10632 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C9 P11712 1/20 0.38
ADRA2B P18089 1/20 0.38
HTR2C P28335 1/20 0.38
P2RX3 P56373 1/20 0.38
SLC6A3 Q01959 1/20 0.38
TMEM97 Q5BJF2 1/20 0.38
P2RX7 Q99572 1/20 0.38
STK39 Q9UEW8 1/20 0.36
NPY2R P49146 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13521949 0.88 CYP3A4 (0.49) CYP3A4PTGDR2PTGDRP2RX4CYP2C8
SCHEMBL348018 0.87 CYP3A4 (0.68) CYP3A4PTGDR2PTGDRP2RX4CYP2C8
SCHEMBL1572613 0.87 CYP3A4 (0.48) CYP3A4PTGDR2PTGDRP2RX4CYP2C8
SCHEMBL13521950 0.86 CYP3A4 (0.49) CYP3A4PTGDR2P2RX4CYP2C9SLC6A3
SCHEMBL349800 0.86 CYP3A4 (0.54) CYP3A4PTGDR2PTGDRP2RX4CYP2C8
SCHEMBL347634 0.85 CYP3A4 (0.47) CYP3A4PTGDR2PTGDRP2RX4CYP2C8
SCHEMBL348013 0.84 CYP3A4 (0.52) CYP3A4PTGDR2PTGDRP2RX4CYP2C8
SCHEMBL12375393 0.84 CYP3A4 (0.45) CYP3A4PTGDR2PTGDRP2RX4CYP2C8
SCHEMBL349244 0.83 CYP3A4 (0.45) CYP3A4PTGDR2PTGDRP2RX4CYP2C8
SCHEMBL13521962 0.83 CYP3A4 (0.61) CYP3A4PTGDR2PTGDRP2RX4NPY2R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010003127-A2 ANTAGONISTS OF PROSTAGLANDIN D2 RECEPTORS AMIRA PHARMACEUTICALS, INC. (US) 2010-01-07 WO disclosed